Director, Global Competitive Intelligence

Revolution Medicines

7d•Remote

About The Position

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting directly to the Executive Director, Global Analytics and Insights, the Competitive Intelligence role requires strategic thinking and expertise to provide critical contributions to brand strategy, launch and life-cycle planning, forecasting, and product and portfolio decisions. This role involves providing comprehensive strategic and competitive insights to support decision-making and strategy-setting across various development programs. The ideal candidate will play a crucial role in monitoring and evaluating the competitive landscape, conducting comprehensive threat assessments, and collaborating with key stakeholders to inform strategic planning. This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.

Requirements

Minimum of 8 years experience in competitive intelligence, market research, or a related field within the pharmaceutical and/or biotechnology industry.
Demonstrated leadership, influencing skills, creativity, problem solving and ability to manage complexity.
Experience in new product launches and pre-launch environments.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.

Nice To Haves

Advanced degree (PhD, Master’s) preferred.
10+ years of experience in competitive intelligence with focus in Oncology.
Demonstrated ability to synthesize complex information and influence decision-making at the executive level.

Responsibilities

Conducts thorough competitive and market assessments to identify market dynamics, trends, and potential impacts on Revolution Medicines’ pipeline, delivering insights to key stakeholders.
Collaborates with stakeholders across the company (including Commercial, Medical Affairs, and R&D) to integrate internal and external information, analytics, and data.
Coordinates and execute coverage of key medical congresses; outputs may include daily and post-conference summaries and post-conference summary presentations.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Benchmarks competitor clinical data, business models and capabilities.
Translates insights into strategic recommendations to inform and influence decision making and strategy setting.
Proactively facilitates the identification and prioritization of intelligence efforts critical to strategic planning and execution for key stakeholders; provides direction for the design and refinement of intelligence plans.
Reinforces Competitive Intelligence best practices, identifies secondary data sources, vendor options, and methodologies that are best suited to address a business need. Manages third parties associated with this function.
Participates in cross-functional teams to gather input for functional activities and to ensure alignment.
Consistently and effectively communicates with key stakeholders in a timely manner to inform on critical updates.